Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Lung Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 29 articles: HTML format

Single Articles

January 2026
1. LOTZ M, Keates S, Carr D, Noor N, et al
   Overactive Bladder Symptoms in Cancer Patients Undergoing Chemotherapy.
   Am J Clin Oncol. 2026;49:25-29.
   PubMed     Abstract available
   
   
   December 2025
2. SHARMA A, Kandoi NM
   Integrating Genomic Data and Imaging in Lung Cancer Prediction Using a Hybrid Deep Learning Approach.
   Am J Clin Oncol. 2025 Dec 26. doi: 10.1097/COC.0000000000001288.
   PubMed     Abstract available
   
   
   
3. SHARMA A, Kandoi NM
   Accurate Lung Cancer Prediction From CT Scans Using Advanced Deep Learning Methods.
   Am J Clin Oncol. 2025 Dec 26. doi: 10.1097/COC.0000000000001286.
   PubMed     Abstract available
   
   
   
4. SHARMA A, Kandoi NM
   Deep Learning-Based Risk Factor Analysis for Accurate Prediction of Lung Cancer in High-Risk Populations.
   Am J Clin Oncol. 2025 Dec 24. doi: 10.1097/COC.0000000000001284.
   PubMed     Abstract available
   
   
   
5. ABDELMONEM A, Bikram Shah B, Shebli MA, Tabbara IA, et al
   Targeted Therapies in Non-Small Cell Lung Cancer: A Contemporary Review.
   Am J Clin Oncol. 2025 Dec 15. doi: 10.1097/COC.0000000000001275.
   PubMed     Abstract available
   
   
   
6. KRISHNAN N, Lee P, Boldt G, Lakkunarajah S, et al
   Immunotherapy in Extensive Stage Small-Cell Lung Cancer in First-Line and Second-Line Setting: A Systematic Review and Meta-Analysis.
   Am J Clin Oncol. 2025 Dec 9. doi: 10.1097/COC.0000000000001265.
   PubMed     Abstract available
   
   
   November 2025
7. YANG D, Cui BH, Wang HY, Zhang ZR, et al
   Prognostic Value of Multiparameter Biomarkers in Pleural Effusion of Patients With Non-small Cell Lung Cancer for Predicting Survival Outcomes: A Prospective Cohort Study.
   Am J Clin Oncol. 2025 Nov 19. doi: 10.1097/COC.0000000000001269.
   PubMed     Abstract available
   
   
   
8. FRIEDES C, Iocolano M, Yegya-Raman N, Kucharczuk JC, et al
   Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy.
   Am J Clin Oncol. 2025 Nov 10. doi: 10.1097/COC.0000000000001260.
   PubMed     Abstract available
   
   
   October 2025
9. CUMMINGS AL, Sussell J, Rosettie KL, El Moustaid F, et al
   A Cost-effectiveness Analysis of Adjuvant Alectinib in Patients With Resectable ALK-positive Non-small Cell Lung Cancer in the United States.
   Am J Clin Oncol. 2025 Oct 8. doi: 10.1097/COC.0000000000001248.
   PubMed     Abstract available
   
   
   July 2025
10. AUGUSTIN M, Lyons K, Kim H, Kim DG, et al
    AI Prognostication in Nonsmall Cell Lung Cancer: A Systematic Review.
    Am J Clin Oncol. 2025 Jul 18. doi: 10.1097/COC.0000000000001238.
    PubMed     Abstract available
    
    
    May 2025
11. GILMORE LA, Willmann J, Olaechea S, Gilmore BW, et al
    Prevalence and Development of Cachexia Before and After Diagnosis of Non-small Cell Lung Cancer.
    Am J Clin Oncol. 2025 May 5. doi: 10.1097/COC.0000000000001211.
    PubMed     Abstract available
    
    
    December 2024
12. SANCHEZ JI, Doose M, Zeruto C, Chollette V, et al
    Assessing the Impact of Multidisciplinary Cancer Consultations on Cancer Quality Metrics.
    Am J Clin Oncol. 2024;47:595-606.
    PubMed     Abstract available
    
    
    November 2024
13. SHAH A, Apple J, Aslam S, Engel-Nitz NM, et al
    Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic Nonsmall-cell Lung Cancer.
    Am J Clin Oncol. 2024 Nov 5. doi: 10.1097/COC.0000000000001155.
    PubMed     Abstract available
    
    
    October 2024
14. GUMUSTEPE E, Yavas G, Kirakli EK, Dincbas FO, et al
    Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).
    Am J Clin Oncol. 2024 Oct 22. doi: 10.1097/COC.0000000000001152.
    PubMed     Abstract available
    
    
    September 2024
15. QURESHI Z, Altaf F, Jamil A, Siddique R, et al
    Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment.
    Am J Clin Oncol. 2024 Sep 11. doi: 10.1097/COC.0000000000001138.
    PubMed     Abstract available
    
    
    June 2024
16. LIU C, Gao F, Yang J, Liu C, et al
    Wilms' Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5.
    Am J Clin Oncol. 2024 Jun 20. doi: 10.1097/COC.0000000000001116.
    PubMed     Abstract available
    
    
    
17. XU J, Tian L, Qi W, Lv Q, et al
    Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.
    Am J Clin Oncol. 2024;47:291-303.
    PubMed     Abstract available
    
    
    May 2024
18. ZHANG T, Hu Y, Yang N, Yu S, et al
    The microRNA-34 Family and Its Functional Role in Lung Cancer.
    Am J Clin Oncol. 2024 May 3. doi: 10.1097/COC.0000000000001106.
    PubMed     Abstract available
    
    
    
19. KASHIWABARA K, Fujii S, Tsumura S, Tokunaga R, et al
    Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction: A Retrospective Single-institution Study.
    Am J Clin Oncol. 2024;47:223-227.
    PubMed     Abstract available
    
    
    April 2024
20. 
    Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior: Erratum.
    Am J Clin Oncol. 2024;47:e1.
    PubMed    
    
    
    
21. LIU X, Shen Q, Wen Y, Jiang Z, et al
    Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
    Am J Clin Oncol. 2024;47:149-154.
    PubMed     Abstract available
    
    
    January 2024
22. CHOU B, Lee JH, Saetern L, Venkatesulu BP, et al
    Bombarding Oligoprogression: Oncologic Outcomes After Radiation to Patients With Oligoprogressive Non-Small Cell Lung Cancer on Maintenance Systemic Therapy.
    Am J Clin Oncol. 2024 Jan 9. doi: 10.1097/COC.0000000000001077.
    PubMed     Abstract available
    
    
    December 2023
23. BRASCHI EL, Morris CG, Yeung AR, De Leo AN, et al
    Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.
    Am J Clin Oncol. 2023 Dec 25. doi: 10.1097/COC.0000000000001081.
    PubMed     Abstract available
    
    
    November 2023
24. ALVAREZ CM, Aliru M, Gannavarapu BS, Song T, et al
    Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2023 Nov 24. doi: 10.1097/COC.0000000000001053.
    PubMed     Abstract available
    
    
    
25. YANG L, Lu X, Luo J, Huang D, et al
    Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer: A Matched-Pair Analysis.
    Am J Clin Oncol. 2023 Nov 20. doi: 10.1097/COC.0000000000001066.
    PubMed     Abstract available
    
    
    
26. CANTRELL JN, Acharya P, Vesely SK, Gunter TC, et al
    Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score-matched NCDB Analysis.
    Am J Clin Oncol. 2023;46:503-511.
    PubMed     Abstract available
    
    
    October 2023
27. ZHAO KX, Zhang YF, Zheng L, Pan YF, et al
    A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation.
    Am J Clin Oncol. 2023 Oct 2. doi: 10.1097/COC.0000000000001047.
    PubMed     Abstract available
    
    
    September 2023
28. YU S, Zhai S, Gong Q, Xiang C, et al
    Neoadjuvant Immunotherapy and Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Am J Clin Oncol. 2023 Sep 26. doi: 10.1097/COC.0000000000001046.
    PubMed     Abstract available
    
    
    
29. ACIKGOZ Y, Yildirim FU, Esen SA, Ucar G, et al
    The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer.
    Am J Clin Oncol. 2023 Sep 13. doi: 10.1097/COC.0000000000001044.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.